Compounds > methylformamide
Page last updated: 2024-08-23

methylformamide and EHS Tumor

methylformamide has been researched along with EHS Tumor in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooksey, PG; Gate, EN; Gescher, A; Hickman, JA; Langdon, SP; Stevens, MF1
Atassi, G; Gescher, A; Gibson, NW; Hickman, JA; Langdon, SP; Ross, D1
Herrmann, R; Osswald, H; Youssef, M1
Fathalla, SA; Harpur, ES; Ishmael, J; Langdon, SP1
Chubb, D; Gescher, A; Hickman, JA; Langdon, SP; Stevens, MF1
Chubb, D; Gescher, A; Hickman, JA; Langdon, SP; Stevens, MF; Vickers, LM1

Other Studies

6 other study(ies) available for methylformamide and EHS Tumor

ArticleYear
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051).
    Biochemical pharmacology, 1983, Oct-15, Volume: 32, Issue:20

    Topics: Animals; Antineoplastic Agents; Formamides; Liver; Lymphoma; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Structure-Activity Relationship

1983
N-methylformamide: antitumour activity and metabolism in mice.
    British journal of cancer, 1982, Volume: 45, Issue:6

    Topics: Animals; Antineoplastic Agents; Female; Formamides; Kinetics; Liver; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Neoplasms, Experimental; Ovarian Neoplasms; Sarcoma, Experimental; Sulfhydryl Compounds

1982
The influence of sodium ascorbate, menadione sodium bisulfite or pyridoxal hydrochloride on the toxic and antineoplastic action of N-methylformamide in P 388 leukemia or M 5076 sarcoma in mice.
    Toxicology, 1987, Volume: 43, Issue:2

    Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Drug Synergism; Female; Formamides; Leukemia P388; Life Expectancy; Mice; Pyridoxal; Sarcoma, Experimental; Vitamin K; Vitamin K 3

1987
The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Urea Nitrogen; Calcium; Cisplatin; Creatinine; Drug Evaluation, Preclinical; Female; Formamides; Injections, Intraperitoneal; Kidney; L-Lactate Dehydrogenase; Lethal Dose 50; Leukocyte Count; Leukopenia; Liver; Male; Mice; Rats; Rats, Inbred F344; Sarcoma, Experimental

1986
Studies on the toxicity of the antitumour agent N-methylformamide in mice.
    Toxicology, 1985, Volume: 34, Issue:2

    Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Cyclophosphamide; Formamides; Granulocytes; L-Iditol 2-Dehydrogenase; Lethal Dose 50; Leukocyte Count; Liver; Mice; Mice, Inbred BALB C; Platelet Count; Sarcoma, Experimental

1985
N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Female; Formamides; Leukocyte Count; Mice; Mice, Inbred Strains; Plasmacytoma; Sarcoma, Experimental

1985